Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Signia Therapeutics logo — Breakthrough Solution for Respiratory Infections

Signia Therapeutics

Breakthrough Solution for Respiratory Infections

Founded 2017 France France 6 employees Grant Total: $3.07M

General Information

Company Name Signia Therapeutics
Founded Year 2017
Location France France +1
Founders / Decision Makers
Team member
Employees 6
Funding Stage Grant
Social

Get notified when Signia Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Signia Therapeutics

Signia Therapeutics is a Lyon, France-based research company with a focus on providing a breakthrough solution for respiratory infections. Founded in 2017, the company has recently received a significant investment of €1.70M in the form of a grant from Bpifrance on 04 January 2022. Signia Therapeutics' dedication to developing innovative treatments for respiratory infections aligns with the growing demand for advanced medical solutions in the healthcare industry. With its promising approach and recent financial backing, Signia Therapeutics appears poised to make impactful strides in addressing respiratory health challenges.

Taxonomy: pharmaceutical research, respiratory infections, antiviral drugs, drug repurposing, clinical trials, medical innovation, viral outbreak response

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
04 Jan 2022
Series A •••••• 1 •••• •••• 20 Oct 2021
Grant •••••• 1 •••• •••• 01 Aug 2018

FAQ About Signia Therapeutics

Breakthrough Solution for Respiratory Infections
Signia Therapeutics was founded in 2017.
Signia Therapeutics is headquartered in France.
Signia Therapeutics has approximately 6 employees.
Signia Therapeutics has completed 3 funding rounds, raising a total of $3.07M. The latest funding stage is Grant.

We're actively collecting intelligence on Signia Therapeutics.

Track Signia Therapeutics to get notified

Don't just browse. Track.

Signal Tracker monitors Signia Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes